Last update 10 May 2025

Corifollitropin alfa (Schering)

Overview

Basic Info

Drug Type
Biosimilar, Hormone
Synonyms-
Target
FSHR
Action
agonists
Mechanism
FSHR agonists(Follicle-stimulating hormone receptor agonists)
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization
Schering-Plough Bermuda Ltd.
Active Organization-
Inactive Organization
Schering-Plough Bermuda Ltd.
License Organization-
Drug Highest PhasePendingIND Application
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Related

1
Clinical Trials associated with Corifollitropin alfa (Schering)
EUCTR2006-003811-36-AT
/ Not yet recruitingNot Applicable
A phase III, randomized, double-blind, active-controlled, equivalence clinical trial to investigate the efficacy and safety of a single injection of 100 µg Org 36286 (corifollitropin alfa) to induce multifollicular development for controlled ovarian stimulation (COS) using daily recombinant FSH (recFSH) as a reference - Ensure
100 Clinical Results associated with Corifollitropin alfa (Schering)
Login to view more data
100 Translational Medicine associated with Corifollitropin alfa (Schering)
Login to view more data
100 Patents (Medical) associated with Corifollitropin alfa (Schering)
Login to view more data
100 Deals associated with Corifollitropin alfa (Schering)
Login to view more data

External Link

KEGGWikiATCDrug Bank
D08895---

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free